Clough Capital Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-59,780
| Closed | -$3.21M | – | 169 |
|
|
2017
Q1 | $3.21M | Sell |
59,780
-5,500
| -8% | -$296K | 0.2% | 81 |
|
|
2016
Q4 | $3.72M | Buy |
65,280
+6,840
| +12% | +$390K | 0.25% | 93 |
|
|
2016
Q3 | $3.63M | Buy |
+58,440
| New | +$3.63M | 0.19% | 112 |
|
|
2016
Q2 | – | Sell |
-59,627
| Closed | -$3.82M | – | 246 |
|
|
2016
Q1 | $3.82M | Buy |
59,627
+8,060
| +16% | +$516K | 0.18% | 119 |
|
|
2015
Q4 | $7.26M | Sell |
51,567
-66,972
| -56% | -$9.42M | 0.34% | 90 |
|
|
2015
Q3 | $11.5M | Buy |
118,539
+6,660
| +6% | +$645K | 0.5% | 65 |
|
|
2015
Q2 | $17M | Buy |
+111,879
| New | +$17M | 0.65% | 56 |
|